Marcus Webb Email & Phone Number

San Diego, California, US

• Sorriso Pharmaceuticals is a Series A funded biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis. The.
• Responsible for management of all CMOs (US and Eu) associated with Bulk Drug Substance production, Drug Product production, analytical activities (assay development, release, stability programs, Reference Standard) for.
• Participate in corporate infrastructure development e.g. QMS, required for early-stage biotech company.

• CnA Consulting Group was founded by two former Life Sciences executives with the goal of providing specialized consulting services to companies in the Life Sciences space. CnA provides consulting services to companies.
• Operations Strategic Analysis and Planning
• Business Plan Development
• Due Diligence, M&A and Integration Strategy
• CMC Strategy
• Supply Chain and Logistics Assessment and Solution Development

• Project Manager for Shire Regenerative Medicine (SRM) Capital expansion / 2nd Site Campus (Project SHORE). Primary activities included; 2nd site selection activities involving interaction with various geographies and.
• Responsible for; selection and management of Architects, Engineers and Construction Managers for project execution; internal SRM team development; campus program direction development and approval.
• Project Manager responsible for development of project schedule, budget and primary companies (Architect, Engineer, Construction Manager) contracting structure.
• Key role in multiple Shire / Advanced BioHealing integration teams during acquisition period to ensure 30 day, 60 day and 90 day post-acquisition goals were achieved.
• Responsible for development and execution of Manufacturing Strategic Plan involving multiple facilities, development of capital budget, and execution of capital projects.
• Responsible for group management activities for Engineering (Operations and Projects), Facilities, Environmental Health & Safety, and space planning personnel.

• Responsible for the management and operation of Manufacturing, Development Engineering, Facilities, Supply Chain and EH&S groups.
• Responsible for Suneva Medical’s initial product Artefill® dermal filler, a collagen/PMMA dermal filler that requires traditional biologics bulk manufacturing processes and aseptic filling of syringes.
• Successes included facility startup completion, media and Artefill® dermal filler process production qualification lots, FDB CA State inspection, KEMA ISO inspection, and FDA Federal inspection.
• Responsible for manufacturing success rate of 100% for media and Artefill® dermal fillers.

• Responsible for management of Engineering, EH&S, Facilities and Validation groups.
• Improved operations management and activity planning for Facilities and Validation groups and rebuilt Engineering and EH&S groups in order to support company growth in areas of manufacturing facilities, execution of.
• Project Management responsibility for ~$21MM manufacturing capital expansion program including negotiation and placement of all primary construction and equipment contracts.
• Managed cross-functional matrix project team with involvement from all major Operations groups to design and execute project.
• Responsible primarily for budget, schedule, execution and delivery of project involving complex solvent based pharmaceutical manufacturing process.

Cambridge, MA, US

• CMC Program Lead for third party external collaboration with PDL involving three therapeutic products.
• Post negotiation, assumed primary responsibility for execution of purchase and sale agreement for the Biogen Idec NIMO facility to Genentech ($408MM).
• Reporting to the CTO, managed FDA PAT program activities and ensured efficient coordination and communication between various stakeholders, consultant(s), and other internal groups (Manufacturing, Engineering.
• Improvement of the business processes, efficiency, and effectiveness of the division through trends, metrics, program reviews and evaluations, analyses, option development and investigations.
• Responsible for the assessment and impact analysis of various scenarios on current and future divisional planning and operational activities.
• Development of corporate manufacturing capacity intelligence database

Paris, France, FR

Msc, Control Engineering

Bsc Iii Hons, Chemical Systems, Automation Eng

Education record